Investors sold shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) on strength during trading on Thursday. $109.92 million flowed into the stock on the tick-up and $173.26 million flowed out of the stock on the tick-down, for a money net flow of $63.34 million out of the stock. Of all companies tracked, Walgreens Boots Alliance had the 0th highest net out-flow for the day. Walgreens Boots Alliance traded up $0.12 for the day and closed at $82.94
Several equities analysts have issued reports on the stock. Barclays upped their target price on shares of Walgreens Boots Alliance from $77.00 to $80.00 and gave the company an “equal weight” rating in a research note on Friday, October 12th. BidaskClub upgraded shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating in a research note on Wednesday, September 12th. Citigroup increased their price objective on shares of Walgreens Boots Alliance from $69.00 to $76.00 and gave the stock a “neutral” rating in a research note on Friday, October 12th. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $81.00 price objective on the stock in a research note on Tuesday, September 25th. Finally, Robert W. Baird increased their price objective on shares of Walgreens Boots Alliance from $64.00 to $69.00 and gave the stock a “neutral” rating in a research note on Tuesday, September 11th. One analyst has rated the stock with a sell rating, eleven have issued a hold rating, seven have issued a buy rating and two have given a strong buy rating to the company’s stock. Walgreens Boots Alliance currently has an average rating of “Hold” and a consensus target price of $79.11.
The firm has a market capitalization of $78.72 billion, a PE ratio of 13.49, a P/E/G ratio of 1.29 and a beta of 0.76. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.38 and a current ratio of 0.82.
Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.45 by $0.03. The company had revenue of $33.44 billion during the quarter, compared to analyst estimates of $33.64 billion. Walgreens Boots Alliance had a net margin of 3.82% and a return on equity of 21.75%. On average, analysts anticipate that Walgreens Boots Alliance Inc will post 6.54 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 12th. Investors of record on Monday, November 12th will be issued a $0.44 dividend. This represents a $1.76 annualized dividend and a yield of 2.17%. The ex-dividend date is Thursday, November 8th. Walgreens Boots Alliance’s dividend payout ratio is 29.24%.
In other Walgreens Boots Alliance news, EVP Kathleen Wilson-Thompson sold 52,000 shares of the stock in a transaction that occurred on Wednesday, October 31st. The shares were sold at an average price of $78.77, for a total transaction of $4,096,040.00. Following the completion of the sale, the executive vice president now directly owns 81,076 shares of the company’s stock, valued at approximately $6,386,356.52. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Nancy M. Schlichting sold 7,050 shares of the stock in a transaction that occurred on Tuesday, November 20th. The shares were sold at an average price of $78.81, for a total transaction of $555,610.50. Following the sale, the director now directly owns 5,709 shares of the company’s stock, valued at $449,926.29. The disclosure for this sale can be found here. Insiders sold a total of 73,756 shares of company stock valued at $5,824,194 over the last three months. 14.80% of the stock is currently owned by insiders.
A number of institutional investors and hedge funds have recently made changes to their positions in WBA. Asset Dedication LLC grew its holdings in shares of Walgreens Boots Alliance by 204.6% in the third quarter. Asset Dedication LLC now owns 1,578 shares of the pharmacy operator’s stock valued at $115,000 after purchasing an additional 1,060 shares in the last quarter. BlueMountain Capital Management LLC purchased a new position in shares of Walgreens Boots Alliance in the second quarter valued at $103,000. CSat Investment Advisory L.P. purchased a new position in shares of Walgreens Boots Alliance in the second quarter valued at $104,000. Capital Advisors Ltd. LLC grew its holdings in shares of Walgreens Boots Alliance by 1,150.3% in the third quarter. Capital Advisors Ltd. LLC now owns 2,063 shares of the pharmacy operator’s stock valued at $150,000 after purchasing an additional 1,898 shares in the last quarter. Finally, Livingston Group Asset Management CO operating as Southport Capital Management purchased a new position in shares of Walgreens Boots Alliance in the third quarter valued at $154,000. 62.59% of the stock is owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY NOTICE: This piece was first reported by Equities Focus and is the property of of Equities Focus. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright legislation. The correct version of this piece can be viewed at https://www.equitiesfocus.com/2018/12/08/traders-sell-walgreens-boots-alliance-wba-on-strength-wba.html.
Walgreens Boots Alliance Company Profile (NASDAQ:WBA)
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Story: Inflation
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.